CI stock · TECH stock

CI vs TECH

Cigna Corp (CI) versus Bio-Techne Corp (TECH) — a side-by-side from cached financials, not a winner call.

Cigna Corp (CI) is a healthcare plans company listed on US.

Bio-Techne Corp (TECH) is a biotechnology company listed on US.

Latest reported CI revenue for 2025-12-31 was $274.90B. Net income was $5.96B. Revenue was up 11.2% from 2024-12-31 to 2025-12-31. CI currently screens at market cap $71.62B and trailing P/E 2.4.

Latest reported TECH revenue for 2025-06-30 was $1.22B. Net income was $73.4M. Revenue was up 5.2% from 2024-06-30 to 2025-06-30. TECH currently screens at market cap $8.49B and trailing P/E 65.2.

CI currently screens at market cap $71.62B and trailing P/E 2.4. TECH currently screens at market cap $8.49B and trailing P/E 65.2.

Not investment advice. Open the CI and TECH stock pages for the full models.

Not investment advice.

Popular Stock Comparisons